Molecule uses hormones to fight diabetes

Share this article:

A team of researchers say a two-hormone approach to type 2 diabetes appears to reduce sugar levels as well as chip away at obesity. The experimental two-in-one combination fuses a GLP-1 and a gastric inhibitory peptide. Digestive processes naturally trigger these two hormones. Researchers say their simulation maximizes the metabolic impact of these hormones which also influence appetite and fat burning. The study incorporated data from Roche and was published in Science Translational Medicine.

Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.